“Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M
See our story on this San Diego specialty-pharmaceutical company in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Cianna Medical receives $9M for breast-cancer radiation treatment devices
Previous Story: Wireless USB on the way — Wisair grabs $24M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.